Shuttle Pharmaceuticals Holdings, Inc.SHPHNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank33
3Y CAGR-12.6%
5Y CAGR-16.4%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-12.6%/yr
Annual compound
5Y CAGR
-16.4%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 71.66% |
| 2023 | 84.06% |
| 2022 | 78.94% |
| 2021 | 107.39% |
| 2020 | 0.00% |
| 2018 | 175.86% |
| 2017 | 0.00% |